It is almost impossible to think of prostate cancer without considering cardiovascular disease. Cardiovascular disease is a major cause of morbidity and mortality   in men over the age of 60—the age range in which prostate cancer is also most common. A significant proportion of men with prostate cancer, then, are also at risk for cardiovascular disease. Hormonal therapy, the standard treatment for men with recurrent aggressive prostate cancer, increases the risk of cardiovascular disease. Charles Myers, MD

View February's publication